EMA press briefing to update on analysis of data on Vaxzevria, the COVID-19 vaccine from AstraZeneca

• Date:
  Friday, 23 April 2021
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

EMA is holding a virtual press briefing to provide an update on the analysis of data on Vaxzevria, the COVID-19 vaccine from AstraZeneca, and the interim opinion issued today by EMA’s human medicines committee, CHMP, aimed at supporting national decision-making on how to best use the vaccine in their territories.

Speakers include:

• Noël Wathion (Deputy Executive Director)
• Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
• Peter Arlett (Head of Data Analytics and Methods Task Force)

The press briefing will be moderated by Marie-Agnes Heine (Head of Communication).

The press briefing will be held in English.

Video recording